| negative regulation of bile acid biosynthetic process | GO:0070858 | 3 | 1.000 | |
| bile acid metabolic process | GO:0008206 | 14 | 1.000 | |
| steroid metabolic process | GO:0008202 | 94 | 1.000 | |
| drug catabolic process | GO:0042737 | 10 | 1.000 | |
| intracellular bile acid receptor signaling pathway | GO:0038185 | 1 | 0.999 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.999 | Rat Worm |
| steroid biosynthetic process | GO:0006694 | 46 | 0.999 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.999 | Rat |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.999 | Human |
| cholesterol homeostasis | GO:0042632 | 28 | 0.999 | Mouse |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.998 | Rat |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.998 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.998 | Rat Worm |
| organic hydroxy compound biosynthetic process | GO:1901617 | 71 | 0.997 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 67 | 0.997 | Rat |
| lipid metabolic process | GO:0006629 | 381 | 0.996 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.996 | Mouse |
| chemical homeostasis | GO:0048878 | 306 | 0.993 | |
| peptide secretion | GO:0002790 | 51 | 0.988 | Mouse |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.988 | Rat |
| bile acid biosynthetic process | GO:0006699 | 10 | 0.985 | |
| endocrine system development | GO:0035270 | 26 | 0.980 | |
| atrial cardiac muscle tissue morphogenesis | GO:0055009 | 1 | 0.979 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.976 | Rat Worm |
| response to low density lipoprotein particle | GO:0055098 | 4 | 0.976 | |
| peptide transport | GO:0015833 | 74 | 0.974 | Mouse |
| lipid transport | GO:0006869 | 90 | 0.972 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.971 | Rat |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.970 | Rat |
| embryonic camera type eye development | GO:0031076 | 2 | 0.963 | |
| pancreas development | GO:0031016 | 19 | 0.963 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.961 | Rat |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.957 | Rat Worm Fly |
| regulation of cholesterol storage | GO:0010885 | 8 | 0.947 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.946 | |
| atrial cardiac muscle tissue development | GO:0003228 | 1 | 0.946 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.930 | |
| oxidation reduction process | GO:0055114 | 396 | 0.928 | Fly |
| response to hormone | GO:0009725 | 175 | 0.923 | |
| epithelium development | GO:0060429 | 227 | 0.922 | Human |
| glandular epithelial cell differentiation | GO:0002067 | 6 | 0.913 | |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.911 | |
| vitamin d receptor signaling pathway | GO:0070561 | 4 | 0.909 | |
| embryonic camera type eye formation | GO:0060900 | 2 | 0.889 | |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.880 | Rat |
| amide transport | GO:0042886 | 76 | 0.875 | Mouse |
| regulation of transcription involved in lymphatic endothelial cell fate commitment | GO:0060849 | 2 | 0.865 | Human |
| exogenous drug catabolic process | GO:0042738 | 8 | 0.858 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.858 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.853 | Rat |
| hindbrain development | GO:0030902 | 3 | 0.848 | |
| response to xenobiotic stimulus | GO:0009410 | 30 | 0.836 | |
| endocrine pancreas development | GO:0031018 | 11 | 0.834 | |
| regulation of steroid metabolic process | GO:0019218 | 32 | 0.826 | |
| regulation of n methyl d aspartate selective glutamate receptor activity | GO:2000310 | 1 | 0.824 | |
| glycolytic process | GO:0006096 | 17 | 0.801 | |
| regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter | GO:0072366 | 1 | 0.794 | |
| pyruvate metabolic process | GO:0006090 | 26 | 0.790 | |
| system process | GO:0003008 | 349 | 0.786 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.781 | Rat |
| negative regulation of lipid biosynthetic process | GO:0051055 | 22 | 0.780 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 54 | 0.778 | Rat |
| drug metabolic process | GO:0017144 | 19 | 0.759 | |
| regulation of smooth muscle cell proliferation | GO:0048660 | 28 | 0.757 | |
| response to steroid hormone | GO:0048545 | 80 | 0.757 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 14 | 0.755 | |
| regulation of transcription involved in cell fate commitment | GO:0060850 | 6 | 0.745 | Human |
| embryonic camera type eye morphogenesis | GO:0048596 | 2 | 0.735 | |
| regulation of secretion | GO:0051046 | 194 | 0.735 | Mouse |
| regulation of cell differentiation | GO:0045595 | 393 | 0.728 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.719 | Rat |
| response to drug | GO:0042493 | 81 | 0.710 | Rat |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.705 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.701 | |
| response to thyroid hormone | GO:0097066 | 9 | 0.697 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.695 | Rat |
| signal release | GO:0023061 | 70 | 0.677 | Mouse |
| lymphatic endothelial cell fate commitment | GO:0060838 | 2 | 0.671 | Human |
| peptide hormone secretion | GO:0030072 | 50 | 0.663 | Mouse |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.662 | Human |
| positive regulation of oxidoreductase activity | GO:0051353 | 26 | 0.662 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.661 | |
| negative regulation of cholesterol storage | GO:0010887 | 4 | 0.651 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.630 | |
| muscle tissue development | GO:0060537 | 62 | 0.622 | |
| lipid homeostasis | GO:0055088 | 39 | 0.621 | |
| monosaccharide metabolic process | GO:0005996 | 74 | 0.618 | Rat |
| regulation of locomotion | GO:0040012 | 329 | 0.610 | Human |
| response to inorganic substance | GO:0010035 | 127 | 0.607 | |
| regulation of oxidoreductase activity | GO:0051341 | 43 | 0.606 | |
| response to monosaccharide | GO:0034284 | 20 | 0.597 | Mouse Rat |
| cellular carbohydrate metabolic process | GO:0044262 | 84 | 0.596 | Rat |
| epithelial cell differentiation | GO:0030855 | 141 | 0.583 | Human |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.577 | |
| regulation of bile acid biosynthetic process | GO:0070857 | 5 | 0.573 | |
| positive regulation of homeostatic process | GO:0032846 | 47 | 0.573 | Mouse |
| cellular hormone metabolic process | GO:0034754 | 41 | 0.567 | |
| regulation of lipid transport by regulation of transcription from rna polymerase ii promoter | GO:0072367 | 4 | 0.565 | |
| regulation of cell migration | GO:0030334 | 289 | 0.564 | Human |
| response to estrogen | GO:0043627 | 47 | 0.558 | |
| cardiac chamber development | GO:0003205 | 30 | 0.558 | |
| sterol homeostasis | GO:0055092 | 28 | 0.555 | Mouse |
| flavonoid metabolic process | GO:0009812 | 8 | 0.552 | |
| epithelial cell fate commitment | GO:0072148 | 3 | 0.550 | Human |
| myeloid leukocyte differentiation | GO:0002573 | 60 | 0.550 | |
| lipid oxidation | GO:0034440 | 33 | 0.539 | Fly |
| response to organonitrogen compound | GO:0010243 | 156 | 0.535 | Rat |
| lens morphogenesis in camera type eye | GO:0002089 | 2 | 0.524 | |
| cardiac atrium development | GO:0003230 | 10 | 0.523 | |
| regulation of steroid biosynthetic process | GO:0050810 | 23 | 0.522 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.522 | Human Mouse Rat |
| regulation of growth | GO:0040008 | 165 | 0.522 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.516 | |
| negative regulation of lipid metabolic process | GO:0045833 | 38 | 0.516 | |
| regulation of lipid transport | GO:0032368 | 44 | 0.513 | |
| maintenance of location | GO:0051235 | 112 | 0.507 | Worm |
| leukocyte differentiation | GO:0002521 | 98 | 0.506 | |
| cell fate determination | GO:0001709 | 3 | 0.497 | |
| renal system development | GO:0072001 | 63 | 0.490 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.485 | |
| xenobiotic transport | GO:0042908 | 1 | 0.484 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.478 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.472 | Mouse |
| cellular response to prostaglandin stimulus | GO:0071379 | 4 | 0.471 | |
| gland development | GO:0048732 | 48 | 0.469 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.461 | |
| tube development | GO:0035295 | 125 | 0.459 | Mouse |
| cardiovascular system development | GO:0072358 | 262 | 0.453 | Human |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.449 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.446 | |
| regulation of male gonad development | GO:2000018 | 4 | 0.439 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.435 | |
| response to lipid | GO:0033993 | 206 | 0.433 | Human |
| response to nitrogen compound | GO:1901698 | 184 | 0.431 | Rat |
| venous blood vessel development | GO:0060841 | 2 | 0.429 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 49 | 0.426 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.424 | |
| organ morphogenesis | GO:0009887 | 147 | 0.419 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.415 | |
| response to nutrient | GO:0007584 | 20 | 0.413 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.411 | |
| positive regulation of cholesterol storage | GO:0010886 | 4 | 0.407 | |
| organic anion transport | GO:0015711 | 103 | 0.407 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.407 | Human |
| hemopoiesis | GO:0030097 | 180 | 0.404 | |
| lens development in camera type eye | GO:0002088 | 2 | 0.403 | |
| positive regulation of sarcomere organization | GO:0060298 | 2 | 0.403 | |
| viral process | GO:0016032 | 146 | 0.402 | Human |
| negative regulation of cytokine mediated signaling pathway | GO:0001960 | 22 | 0.390 | |
| stem cell development | GO:0048864 | 69 | 0.388 | |
| anion transport | GO:0006820 | 161 | 0.387 | |
| hepaticobiliary system development | GO:0061008 | 10 | 0.384 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.379 | |
| innate immune response | GO:0045087 | 178 | 0.376 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.375 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 11 | 0.369 | Rat |
| hormone transport | GO:0009914 | 68 | 0.368 | Mouse |
| cell development | GO:0048468 | 328 | 0.367 | |
| cellular response to nutrient | GO:0031670 | 12 | 0.367 | |
| regulation of immune response | GO:0050776 | 201 | 0.363 | |
| limbic system development | GO:0021761 | 3 | 0.363 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.359 | |
| endothelial cell fate commitment | GO:0060839 | 3 | 0.356 | Human |
| regulation of viral process | GO:0050792 | 103 | 0.356 | |
| viral life cycle | GO:0019058 | 132 | 0.356 | |
| rhythmic process | GO:0048511 | 31 | 0.353 | |
| muscle cell proliferation | GO:0033002 | 35 | 0.350 | |
| circulatory system development | GO:0072359 | 262 | 0.348 | Human |
| generation of precursor metabolites and energy | GO:0006091 | 68 | 0.344 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.343 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 | 0.342 | |
| ion homeostasis | GO:0050801 | 230 | 0.335 | Mouse |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.333 | |
| regulation of heart growth | GO:0060420 | 4 | 0.332 | |
| lipid catabolic process | GO:0016042 | 84 | 0.322 | Fly |
| fatty acid metabolic process | GO:0006631 | 115 | 0.319 | Rat Worm |
| pronephros morphogenesis | GO:0072114 | 1 | 0.318 | |
| response to metal ion | GO:0010038 | 84 | 0.317 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.315 | |
| reproductive system development | GO:0061458 | 56 | 0.313 | |
| metencephalon development | GO:0022037 | 2 | 0.312 | |
| positive regulation of male gonad development | GO:2000020 | 3 | 0.311 | |
| cardiac ventricle development | GO:0003231 | 23 | 0.309 | |
| response to hypoxia | GO:0001666 | 96 | 0.305 | |
| insulin secretion | GO:0030073 | 39 | 0.303 | Mouse |
| blastocyst formation | GO:0001825 | 3 | 0.298 | |
| single organism carbohydrate catabolic process | GO:0044724 | 33 | 0.294 | |
| response to acid chemical | GO:0001101 | 66 | 0.294 | Human |
| regulation of cell motility | GO:2000145 | 299 | 0.291 | Human |
| regulation of homeostatic process | GO:0032844 | 121 | 0.290 | Mouse |
| smooth muscle cell proliferation | GO:0048659 | 28 | 0.289 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.287 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.284 | |
| blood vessel development | GO:0001568 | 172 | 0.284 | |
| otic vesicle development | GO:0071599 | 1 | 0.283 | |
| drug transport | GO:0015893 | 8 | 0.283 | |
| positive regulation of cyclin dependent protein serine threonine kinase activity | GO:0045737 | 15 | 0.283 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.282 | |
| regulation of glucose metabolic process | GO:0010906 | 28 | 0.276 | Rat |
| regulation of insulin secretion | GO:0050796 | 33 | 0.275 | Mouse |
| interferon gamma mediated signaling pathway | GO:0060333 | 7 | 0.275 | |
| cellular response to insulin stimulus | GO:0032869 | 41 | 0.275 | |
| secretion | GO:0046903 | 254 | 0.274 | Mouse |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.274 | |
| regulation of cellular carbohydrate catabolic process | GO:0043471 | 11 | 0.272 | |
| blastocyst development | GO:0001824 | 3 | 0.270 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.268 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.264 | Rat |
| vasculature development | GO:0001944 | 181 | 0.263 | Human |
| regulation of blood pressure | GO:0008217 | 30 | 0.262 | |
| ectodermal placode formation | GO:0060788 | 1 | 0.261 | |
| atp metabolic process | GO:0046034 | 176 | 0.261 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.260 | |
| single organism reproductive process | GO:0044702 | 98 | 0.255 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.255 | |
| response to fatty acid | GO:0070542 | 13 | 0.253 | |
| epidermal cell differentiation | GO:0009913 | 45 | 0.252 | |
| placenta development | GO:0001890 | 10 | 0.248 | |
| response to glucose | GO:0009749 | 19 | 0.248 | Mouse Rat |
| endothelial cell migration | GO:0043542 | 86 | 0.247 | Human |
| response to extracellular stimulus | GO:0009991 | 85 | 0.247 | |
| sequestering of triglyceride | GO:0030730 | 11 | 0.246 | |
| response to alcohol | GO:0097305 | 64 | 0.243 | |
| regulation of sequestering of triglyceride | GO:0010889 | 8 | 0.241 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.239 | |
| development of primary male sexual characteristics | GO:0046546 | 23 | 0.237 | |
| regulation of circadian rhythm | GO:0042752 | 11 | 0.236 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 38 | 0.235 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.235 | |
| secretion by cell | GO:0032940 | 226 | 0.234 | Mouse |
| cellular response to thyroid hormone stimulus | GO:0097067 | 9 | 0.232 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 3 | 0.227 | |
| cerebellum development | GO:0021549 | 2 | 0.225 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.224 | |
| muscle structure development | GO:0061061 | 98 | 0.222 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.219 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.216 | |
| hepatocyte differentiation | GO:0070365 | 1 | 0.215 | |
| maternal placenta development | GO:0001893 | 5 | 0.214 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.213 | |
| reproductive structure development | GO:0048608 | 55 | 0.212 | |
| ventricular cardiac muscle cell differentiation | GO:0055012 | 1 | 0.212 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 79 | 0.211 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.207 | |
| liver development | GO:0001889 | 9 | 0.207 | |
| cell morphogenesis | GO:0000902 | 296 | 0.206 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.205 | |
| regulation of viral genome replication | GO:0045069 | 48 | 0.200 | |
| stem cell differentiation | GO:0048863 | 93 | 0.199 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.199 | |
| cardiac septum morphogenesis | GO:0060411 | 9 | 0.199 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.198 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 47 | 0.198 | Rat |
| tissue migration | GO:0090130 | 119 | 0.197 | Human |
| regulation of transporter activity | GO:0032409 | 82 | 0.196 | |
| immune response | GO:0006955 | 307 | 0.195 | |
| glucose homeostasis | GO:0042593 | 31 | 0.195 | Mouse |
| cardiac chamber morphogenesis | GO:0003206 | 26 | 0.194 | |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.193 | |
| regulation of ion transport | GO:0043269 | 189 | 0.192 | |
| response to oxidative stress | GO:0006979 | 121 | 0.191 | |
| glutamate receptor signaling pathway | GO:0007215 | 23 | 0.190 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.189 | Rat |
| carbohydrate catabolic process | GO:0016052 | 36 | 0.186 | |
| cellular homeostasis | GO:0019725 | 196 | 0.185 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.184 | |
| cholesterol storage | GO:0010878 | 9 | 0.183 | |
| negative regulation of response to interferon gamma | GO:0060331 | 2 | 0.182 | |
| response to oxygen levels | GO:0070482 | 100 | 0.182 | |
| skeletal muscle thin filament assembly | GO:0030240 | 3 | 0.180 | |
| cellular response to acid chemical | GO:0071229 | 44 | 0.180 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 14 | 0.178 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.178 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.178 | Rat |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.177 | |
| regulation of kidney size | GO:0035564 | 2 | 0.175 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.173 | |
| androgen metabolic process | GO:0008209 | 9 | 0.172 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 109 | 0.171 | |
| positive regulation of hormone secretion | GO:0046887 | 25 | 0.170 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.168 | |
| regulation of cell development | GO:0060284 | 161 | 0.168 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.167 | |
| ureteric bud elongation | GO:0060677 | 2 | 0.167 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 43 | 0.166 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.166 | |
| receptor biosynthetic process | GO:0032800 | 18 | 0.165 | |
| hexose metabolic process | GO:0019318 | 55 | 0.165 | Rat |
| negative regulation of transport | GO:0051051 | 176 | 0.162 | Rat |
| response to vitamin d | GO:0033280 | 10 | 0.160 | |
| response to nutrient levels | GO:0031667 | 81 | 0.160 | |
| cardiac ventricle morphogenesis | GO:0003208 | 20 | 0.160 | |
| urogenital system development | GO:0001655 | 65 | 0.160 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.158 | |
| positive regulation of transport | GO:0051050 | 336 | 0.157 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.156 | |
| regulation of lipid storage | GO:0010883 | 21 | 0.155 | |
| response to carbohydrate | GO:0009743 | 21 | 0.155 | Mouse Rat |
| viral genome replication | GO:0019079 | 50 | 0.154 | |
| negative regulation of icosanoid secretion | GO:0032304 | 2 | 0.153 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.153 | |
| response to activity | GO:0014823 | 0 | 0.152 | |
| muscle organ morphogenesis | GO:0048644 | 19 | 0.152 | |
| mesonephric duct development | GO:0072177 | 3 | 0.151 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.151 | Human |
| cell differentiation in hindbrain | GO:0021533 | 1 | 0.148 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.147 | Human Rat |
| regulation of cellular component movement | GO:0051270 | 334 | 0.147 | Human |
| purine nucleotide biosynthetic process | GO:0006164 | 84 | 0.147 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.146 | |
| cellular response to interferon gamma | GO:0071346 | 24 | 0.146 | |
| vitamin e metabolic process | GO:0042360 | 1 | 0.145 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 109 | 0.144 | |
| protein maturation | GO:0051604 | 233 | 0.144 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.144 | |
| hormone mediated signaling pathway | GO:0009755 | 22 | 0.144 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.143 | Human |
| embryonic retina morphogenesis in camera type eye | GO:0060059 | 1 | 0.143 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.143 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.142 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.142 | |
| regulation of innate immune response | GO:0045088 | 97 | 0.140 | |
| growth | GO:0040007 | 202 | 0.139 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.139 | |
| regulation of hormone secretion | GO:0046883 | 57 | 0.139 | Mouse |
| skeletal system development | GO:0001501 | 79 | 0.137 | |
| sensory organ morphogenesis | GO:0090596 | 21 | 0.136 | |
| chromatin organization | GO:0006325 | 351 | 0.136 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.136 | Mouse |
| lipid modification | GO:0030258 | 84 | 0.136 | Fly |
| mitochondrion organization | GO:0007005 | 156 | 0.135 | |
| cranial nerve development | GO:0021545 | 4 | 0.134 | |
| regulation of fatty acid metabolic process | GO:0019217 | 24 | 0.132 | Rat Worm |
| regulation of cholesterol homeostasis | GO:2000188 | 2 | 0.132 | Mouse |
| regulation of glycolytic process | GO:0006110 | 10 | 0.131 | |
| monocyte differentiation | GO:0030224 | 15 | 0.130 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.129 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.129 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.129 | |
| negative regulation of smooth muscle cell proliferation | GO:0048662 | 14 | 0.127 | |
| ventricular septum development | GO:0003281 | 5 | 0.126 | |
| ribonucleotide biosynthetic process | GO:0009260 | 81 | 0.126 | |
| negative regulation of steroid biosynthetic process | GO:0010894 | 15 | 0.126 | |
| locomotory behavior | GO:0007626 | 1 | 0.125 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 83 | 0.125 | |
| embryonic organ morphogenesis | GO:0048562 | 24 | 0.125 | |
| cellular response to extracellular stimulus | GO:0031668 | 72 | 0.124 | |
| cellular carbohydrate catabolic process | GO:0044275 | 17 | 0.123 | |
| cellular response to fatty acid | GO:0071398 | 8 | 0.122 | |
| post embryonic development | GO:0009791 | 2 | 0.122 | Worm |
| cytokine mediated signaling pathway | GO:0019221 | 109 | 0.121 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.120 | |
| positive regulation of vitamin d 24 hydroxylase activity | GO:0010980 | 3 | 0.120 | |
| regulation of organelle assembly | GO:1902115 | 40 | 0.119 | |
| glucose metabolic process | GO:0006006 | 45 | 0.119 | Rat |
| regulation of cell cycle | GO:0051726 | 393 | 0.118 | Human Rat |
| striated muscle tissue development | GO:0014706 | 59 | 0.118 | |
| lipid localization | GO:0010876 | 106 | 0.117 | Worm |
| immune system development | GO:0002520 | 195 | 0.117 | |
| negative regulation of viral process | GO:0048525 | 66 | 0.117 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.117 | Human Rat |
| positive regulation of cell migration | GO:0030335 | 172 | 0.117 | |
| alanine metabolic process | GO:0006522 | 4 | 0.116 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.116 | |
| positive regulation of organ growth | GO:0046622 | 2 | 0.115 | |
| regeneration | GO:0031099 | 4 | 0.115 | |
| heart development | GO:0007507 | 95 | 0.114 | |
| ectodermal placode development | GO:0071696 | 1 | 0.114 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.113 | Mouse |
| positive regulation of locomotion | GO:0040017 | 186 | 0.112 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.112 | Human |
| embryo development | GO:0009790 | 123 | 0.111 | Mouse Worm |
| gland morphogenesis | GO:0022612 | 8 | 0.110 | |
| protein processing | GO:0016485 | 226 | 0.110 | |
| response to insulin | GO:0032868 | 45 | 0.110 | |
| keratinocyte proliferation | GO:0043616 | 17 | 0.110 | |
| hormone secretion | GO:0046879 | 65 | 0.109 | Mouse |
| cellular response to peptide | GO:1901653 | 59 | 0.109 | |
| cellular response to inorganic substance | GO:0071241 | 45 | 0.108 | |
| epithelial cell development | GO:0002064 | 34 | 0.107 | |
| pyruvate family amino acid metabolic process | GO:0009078 | 4 | 0.107 | |
| organic acid transport | GO:0015849 | 65 | 0.107 | |
| hippocampus development | GO:0021766 | 1 | 0.107 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 186 | 0.106 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.106 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 27 | 0.106 | |
| drug export | GO:0046618 | 1 | 0.105 | |
| enteroendocrine cell differentiation | GO:0035883 | 6 | 0.105 | |
| cellular response to oxygen levels | GO:0071453 | 55 | 0.104 | |
| response to hexose | GO:0009746 | 20 | 0.104 | Mouse Rat |
| energy homeostasis | GO:0097009 | 3 | 0.103 | |
| ribose phosphate biosynthetic process | GO:0046390 | 82 | 0.103 | |
| endothelial cell proliferation | GO:0001935 | 65 | 0.103 | Human |
| negative regulation of cell death | GO:0060548 | 345 | 0.103 | |
| regulation of sarcomere organization | GO:0060297 | 3 | 0.103 | |
| regulation of endothelial cell proliferation | GO:0001936 | 56 | 0.102 | Human |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 9 | 0.102 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.101 | |
| response to cytokine | GO:0034097 | 232 | 0.100 | |
| regulation of cytokine mediated signaling pathway | GO:0001959 | 41 | 0.097 | |
| purine ribonucleoside biosynthetic process | GO:0046129 | 23 | 0.097 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.096 | |
| negative regulation of response to cytokine stimulus | GO:0060761 | 25 | 0.095 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.095 | Mouse |
| regulation of response to interferon gamma | GO:0060330 | 7 | 0.094 | |
| defense response | GO:0006952 | 315 | 0.094 | |
| circadian rhythm | GO:0007623 | 21 | 0.094 | |
| transmembrane transport | GO:0055085 | 399 | 0.092 | |
| regulation of receptor biosynthetic process | GO:0010869 | 15 | 0.091 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.091 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.091 | |
| regulation of peptide hormone secretion | GO:0090276 | 41 | 0.091 | Mouse |
| nervous system development | GO:0007399 | 293 | 0.091 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.091 | |
| positive regulation of epithelial cell differentiation | GO:0030858 | 14 | 0.090 | |
| sex differentiation | GO:0007548 | 45 | 0.090 | Mouse |
| respiratory tube development | GO:0030323 | 20 | 0.090 | |
| negative regulation of smooth muscle cell migration | GO:0014912 | 7 | 0.090 | |
| circadian regulation of gene expression | GO:0032922 | 8 | 0.089 | |
| epidermis development | GO:0008544 | 59 | 0.089 | |
| negative regulation of viral genome replication | GO:0045071 | 35 | 0.089 | |
| actin filament based process | GO:0030029 | 224 | 0.088 | |
| cardiac septum development | GO:0003279 | 13 | 0.088 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.088 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.088 | |
| multicellular organismal homeostasis | GO:0048871 | 67 | 0.087 | |
| negative regulation of steroid metabolic process | GO:0045939 | 15 | 0.086 | |
| cellular response to vitamin d | GO:0071305 | 5 | 0.086 | |
| organic hydroxy compound transport | GO:0015850 | 63 | 0.086 | |
| regulation of ion transmembrane transport | GO:0034765 | 132 | 0.086 | |
| cellular response to lipid | GO:0071396 | 127 | 0.086 | |
| muscle organ development | GO:0007517 | 56 | 0.086 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.085 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.085 | |
| hepatocyte proliferation | GO:0072574 | 1 | 0.085 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.085 | |
| regulation of glycolytic by positive regulation of transcription from rna polymerase ii promoter | GO:0072363 | 1 | 0.085 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.084 | Worm |
| skeletal myofibril assembly | GO:0014866 | 3 | 0.084 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.083 | |
| nicotinate transport | GO:2001142 | 1 | 0.083 | |
| circulatory system process | GO:0003013 | 113 | 0.082 | |
| negative regulation of sequestering of triglyceride | GO:0010891 | 5 | 0.082 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.082 | |
| aorta morphogenesis | GO:0035909 | 1 | 0.082 | |
| pallium development | GO:0021543 | 10 | 0.081 | |
| actin filament organization | GO:0007015 | 128 | 0.080 | |
| cardiac atrium morphogenesis | GO:0003209 | 7 | 0.080 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.080 | |
| regulation of epidermal cell differentiation | GO:0045604 | 15 | 0.080 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.079 | |
| cholesterol transport | GO:0030301 | 39 | 0.079 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.079 | |
| acylglycerol homeostasis | GO:0055090 | 14 | 0.079 | Mouse |
| pancreatic a cell differentiation | GO:0003310 | 1 | 0.079 | |
| kidney development | GO:0001822 | 53 | 0.078 | |
| sterol transport | GO:0015918 | 39 | 0.078 | |
| purine nucleoside biosynthetic process | GO:0042451 | 23 | 0.078 | |
| regulation of carbohydrate catabolic process | GO:0043470 | 11 | 0.078 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.078 | |
| dna templated transcription initiation | GO:0006352 | 35 | 0.078 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 48 | 0.077 | Human |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 14 | 0.077 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.077 | Human |
| cellular response to vitamin | GO:0071295 | 6 | 0.077 | |
| response to peptide | GO:1901652 | 65 | 0.077 | |
| thymus development | GO:0048538 | 3 | 0.076 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 3 | 0.076 | |
| epithelial cell migration | GO:0010631 | 119 | 0.076 | Human |
| positive regulation of muscle cell differentiation | GO:0051149 | 15 | 0.076 | |
| negative regulation of response to wounding | GO:1903035 | 47 | 0.076 | |
| zymogen activation | GO:0031638 | 70 | 0.075 | |
| artery morphogenesis | GO:0048844 | 7 | 0.075 | |
| positive regulation of protein complex assembly | GO:0031334 | 86 | 0.075 | |
| regulation of muscle tissue development | GO:1901861 | 26 | 0.075 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.074 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.074 | |
| bile acid signaling pathway | GO:0038183 | 3 | 0.074 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.074 | |
| positive regulation of nervous system development | GO:0051962 | 54 | 0.074 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.074 | |
| retinoic acid receptor signaling pathway | GO:0048384 | 13 | 0.073 | Human |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.073 | |
| decidualization | GO:0046697 | 4 | 0.072 | |
| cardiac muscle cell differentiation | GO:0055007 | 15 | 0.072 | |
| vitamin k catabolic process | GO:0042377 | 2 | 0.072 | |
